Article
Effects of genetic variation at the CYP2C19/CYP2C9 locus on pharmacokinetics of chlorcycloguanil in adult Gambians.
Pharmacogenomics - 1 Sept 2009
Janha Ramatoulie E, Sisay-Joof Fatoumatta, Hamid-Adiamoh Majidah, Worwui Archibald, Chapman Hannah L, Opara Hyginus, Dunyo Sam, Milligan Paul, Rockett Kirk, Winstanley Peter, Pirmohamed Munir, Miller Ann K, Conway David J, Walton Robert T
Abstract excerpt
AIMS: Antimalarial biguanides are metabolized by CYP2C19, thus genetic variation at the CYP2C locus might affect pharmacokinetics and so treatment outcome for malaria. MATERIALS & METHODS: Polymorphisms in CYP2C19 and CYP2C9 in 43 adult Gambians treated with chlorproguanil/dapsone for uncomplicated malaria were assessed. Chlorcycloguanil pharmacokinetics were measured and associations with CYP2C19 and CYP2C9...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
